NEW YORK, Aug. 15, 2019 /PRNewswire/ -- The US Navy Veterans Mesothelioma Advocate says, "We are the top ranked source on the Internet for US Navy Vete

MILFORD, Conn., Aug. 15, 2019 /PRNewswire/ -- As the world celebrates the 50th anniversary of Apollo 11 landing on the moon, an interest and passion for deep-space travel has been reignited throughout the country. For the first time in a generation, NASA is building a human spacecraft for deep-space missions that will be the catalyst for a new space exploratio

PHOENIX, Aug. 15, 2019 /PRNewswire/ -- In June, Health Outreach Partners' (HOP) featured Providertech as an innovative outreach practice leveraging technology to create trusting relationships, ensure access to health care, and improve self-management of care for vulnerable populations.HOP began publishing Innovative Outreach Practices (IOPs Reports) in 2002 to sho

MANHASSET, N.Y., Aug. 15, 2019 /PRNewswire/ -- The Feinstein Institutes for Medical Research Professor

STERLING, Va., Aug. 15, 2019 /PRNewswire/ -- Aperiomics, the fast-growing biotech company combining the latest advancements in science, technology, and medicine to change the way healthcare provider

NEW YORK and CAESAREA, Israel, Aug. 15, 2019 /PRNewswire/ -- DarioHealth Corp. ("DarioHealth" or "Dario") (Nasdaq: DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London ("DH.L") as part of i

VANCOUVER, British Columbia, Aug. 15, 2019 /PRNewswire/ -- MYM Nutraceuticals Inc., (CSE: MYM.CN) (MYM.CN) (OTCBB: MYMMF) ("MYM Nutraceuticals" or the "Company") announces it has determined that the amount of biomass anticipated to be cultivated by BioHemp Naturals Growing & Farming Ltd. ("Bio Hemp") on its Sas

SHANGHAI, Aug. 15, 2019 /PRNewswire/ -- Starting in August 2019, 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, will launch "111 Insight", a video series on the development of the healthcare industry in China.The series is produced by 111,

SAN DIEGO, Aug. 15, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company, developing drugs that target cell division (mitosis), for the treatment of various cancers, including prostate, colorectal and leukemia, today announced that new clinical data from its Phase 2 trial of o

CAESAREA, Israel, Aug. 15, 2019 /PRNewswire/ -- V-Wave Ltd., a privately held medical device company developing novel implantable interatrial shunt devices, today announced that the U.S. Food and Drug Administration (FDA) has just granted the company a Breakthrough Device Designation for its interatrial shunt for Heart Failure (HF). V-Wave's minimally invasive, impl